 | (R)-3-((2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidin-1-yl)sulfonyl)phenol | IC50 | 0.9 [1], 3.71 [2] |
 | Clozapine | Ki | 12.59 [1], 48.0 [2] |
 | Serotonin | IC50 | 1.5 [1] |
 | Methiothepin | IC50 | 1.5 [1], 3.1 [2], 21.0 [3] |
| Methiothepin | Ki | 0.9 [1], 1.0 [2], 1.7 [3], 3.7 [4] |
 | Olanzapine | Ki | 79.43 [1], 185.0 [2], 206.0 [3], 365.0 [4], 1000.0 [5] |
 | 2a-[4-(4-Phenylpiperazin-1-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one | Ki | 2.14 [1], 3.16 [2], 3.31 [3] |
 | 2a-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one | Ki | 2.14 [1], 5.01 [2], 5.13 [3] |
 | Chlorpromazine | Ki | 10.72 [1], 27.0 [2], 31.62 [3], 119.0 [4] |
 | Risperidone | Ki | 0.4 [1], 1.0 [2], 4.3 [3], 10.0 [4] |
 | Mianserin | IC50 | 114.82 [1] |
| Mianserin | Ki | 56.0 [1], 63.1 [2], 8010.0 [3] |
 | Spiperone | Ki | 19.95 [1], 110.0 [2] |
 | 4-Methyl-1-[2-[(2R)-1-(3-methylphenyl)sulfonylpyrrolidin-2-yl]ethyl]piperidine | Ki | 3.0 [1], 3.16 [2] |
 | CID 10028436 | Ki | 2.0 [1], 3.2 [2] |
 | 2a-[4-(4-Cyclohexylpiperazin-1-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one | Ki | 1000.0 [1], 10000.0 [2], 100000.0 [3] |
 | 2a-[3-(4-Phenylpiperazin-1-yl)propyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one | Ki | 5.0 [1], 5.01 [2], 5.25 [3] |
 | 2-[4-[4-(2-Oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butyl]piperazin-1-yl]benzonitrile | Ki | 3.8 [1], 3.98 [2] |
 | 2a-[4-(4-Pyridin-2-ylpiperazin-1-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one | Ki | 1.86 [1], 2.0 [2] |
 | 1-(2-Methoxy-phenyl)-4-(1-o-tolyl-1H-pyrrol-3-ylmethyl)-piperazine | Ki | 4.3 [1], 4.7 [2], 21.0 [3] |
 | 3-[3-(4-Benzhydrylpiperazin-1-yl)-2-hydroxypropyl]-5-(4-fluorophenyl)-5-methylimidazolidine-2,4-dione | IC50 | 1807.0 [1] |
| 3-[3-(4-Benzhydrylpiperazin-1-yl)-2-hydroxypropyl]-5-(4-fluorophenyl)-5-methylimidazolidine-2,4-dione | Ki | 79.0 [1] |
 | Haloperidol | Ki | 316.23 [1], 408.0 [2], 1122.02 [3] |
 | 8-OH-Dpat | Ki | 388.0 [1], 466.0 [2] |
 | Ziprasidone | Ki | 5.0 [1], 5.01 [2], 6.0 [3] |
 | Mesulergine | IC50 | 120.0 [1], 290.0 [2] |
| Mesulergine | Ki | 7.94 [1] |
 | 6-[4-(2-Methylsulfanylphenyl)piperazin-1-yl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)hexanamide | Ki | 0.22 [1] |
 | 1-[4-(3,4-Dihydro-1H-isoquinolin-2-yl)butyl]-3H-indol-2-one | Ki | 7.0 [1] |
 | (2S)-1-(1-Naphthylsulfonyl)-2-[2-(4-methylpiperidino)ethyl]pyrrolidine | Ki | 10.0 [1], 398.11 [2], 400.0 [3] |
 | 2a-[2-(4-Phenylpiperazin-1-yl)ethyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one | Ki | 100.0 [1], 102.33 [2] |
 | N-Methyl-N-[4-(3-methylpiperidin-1-yl)butan-2-yl]naphthalene-1-sulfonamide | Ki | 63.1 [1], 65.0 [2] |
 | 6-Chloro-2a-[4-[4-(4-chlorophenyl)-3,6-dihydro-2H-pyridin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one | Ki | 7.24 [1] |
 | N-Methyl-2-[2-[4-(2-oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butyl]-3,4-dihydro-1H-pyrido[3,4-b]indol-9-yl]acetamide | Ki | 3.55 [1], 4.0 [2] |
 | N-(Diaminomethylidene)-9-hydroxy-9-methylfluorene-2-carboxamide;hydrochloride | IC50 | 59.0 [1] |
| N-(Diaminomethylidene)-9-hydroxy-9-methylfluorene-2-carboxamide;hydrochloride | Ki | 4.3 [1] |
 | 2-Bromo-6-[2-(dimethylamino)ethylthio]pyridine | Ki | 4.1 [1], 37.0 [2] |
 | 2-Phenyl-6-[2-(dimethylamino)ethylthio]pyridine | Ki | 0.6 [1], 6.2 [2] |
 | (3S)-2-[5-[4-(2-Phenylphenyl)piperazin-1-yl]pentanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxamide | Ki | 6.0 [1], 12.0 [2], 94.0 [3] |
 | 5-[4-(2-Phenylphenyl)piperazin-1-yl]-1-[(2S)-2-(piperidine-1-carbonyl)pyrrolidin-1-yl]pentan-1-one | Ki | 5.0 [1], 20.0 [2], 91.0 [3] |
 | Quetiapine | Ki | 63.1 [1], 1000.0 [2] |
 | Lysergide | Ki | 6.31 [1], 6.6 [2] |
 | Ritanserin | Ki | 15.85 [1], 45.0 [2] |
 | Metergoline | Ki | 6.31 [1] |
 | Vortioxetine | Ki | 26.0 [1] |
 | Latrepirdine | Ki | 7.94 [1], 8.0 [2] |
 | 5-Chloro-N-(4-methoxy-3-(piperazin-1-yl)phenyl)-3-methylbenzo[b]thiophene-2-sulfonamide | Ki | 260.0 [1], 3981.07 [2] |
 | 2-Bromolysergic acid diethylamide | Ki | 10.0 [1], 30.0 [2] |
 | 2-[1-(Benzenesulfonyl)-5-methoxyindol-3-yl]-N,N-dimethylethanamine | Ki | 600.0 [1], 1900.0 [2] |
 | 2-Ethyl-5-methoxy-N,N-dimethyltryptamine | IC50 | 1500.0 [1] |
| 2-Ethyl-5-methoxy-N,N-dimethyltryptamine | Ki | 300.0 [1] |
 | N,N-Diallyl-5-methoxytryptamine | Ki | 16.98 [1], 89.13 [2] |
 | 3-Methyl-2-((R)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-11-yl)-benzonitrile | Ki | 1.0 [1], 3.79 [2] |
 | (2S)-(+)-5-(1,3,5-Trimethylpyrazol-4-YL)-2-(dimethylamino)tetralin | Ki | 0.6 [1] |
 | Indole, 3-(2-(dimethylamino)ethyl)-5-methoxy-2-methyl- | Ki | 145.0 [1], 1260.0 [2] |
 | 1-[5-(4-Phenylpiperazin-1-yl)pentyl]benzo[cd]indol-2-one | Ki | 89.0 [1] |
 | (6S,14R)-6-Methoxy-6,13-dimethyl-13-azapentacyclo[12.3.1.05,17.07,16.010,15]octadeca-1(17),2,4,7(16),8,10(15)-hexaene | Ki | 1.1 [1] |
 | Piperazine, 1-(4'-methoxy(1,1'-biphenyl)-2-yl)- | IC50 | 438.0 [1] |
| Piperazine, 1-(4'-methoxy(1,1'-biphenyl)-2-yl)- | Ki | 2.6 [1] |
 | 5-Chloro-N-[4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]-3-methyl-1-benzothiophene-2-sulfonamide | Ki | 3162.28 [1] |
 | (6R,14R)-6-Methoxy-6,13-dimethyl-13-azapentacyclo[12.3.1.05,17.07,16.010,15]octadeca-1(17),2,4,7(16),8,10(15)-hexaene | Ki | 1.1 [1] |
 | (2R)-1-(1-Naphthylsulfonyl)-2-[2-(4-methylpiperidino)ethyl]pyrrolidine | Ki | 10.0 [1] |
 | 3-{4-[4-(4-Chlorophenyl)-piperazin-1-yl]-butyl}-3-ethyl-6-fluoro-1,3-dihydro-2H-indol-2-one | Ki | 0.79 [1] |
 | N-[3-[4-(2-Methoxyphenyl)piperazin-1-yl]propyl]naphthalene-2-sulfonamide | IC50 | 20.0 [1] |
| N-[3-[4-(2-Methoxyphenyl)piperazin-1-yl]propyl]naphthalene-2-sulfonamide | Ki | 20.0 [1] |
 | 2,8-Dimethyl-5-phenethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole | Ki | 0.15 [1], 0.25 [2] |
 | 3-[2-[4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]-N-(pyridin-4-ylmethyl)propanamide | Ki | 18.0 [1] |
 | 3-[2-[4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]-N-(pyridin-3-ylmethyl)propanamide | Ki | 23.8 [1] |
 | 3-[2-[4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]-N-(pyridin-2-ylmethyl)propanamide | Ki | 23.5 [1] |
 | 6-[4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl]-N-(pyridin-4-ylmethyl)hexanamide | Ki | 11.2 [1] |
 | 6-[4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl]-N-(pyridin-2-ylmethyl)hexanamide | Ki | 15.2 [1] |
 | 6-[4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl]-N-(pyridin-3-ylmethyl)hexanamide | Ki | 12.7 [1] |
 | 2-Cyclohexyl-6-[2-(dimethylamino)ethylthio]pyridine | Ki | 0.7 [1] |
 | 2-[2-[6-(Trifluoromethyl)indol-1-yl]ethyl]-3,4,5,7,8,9,10,10a-octahydro-1H-pyrido[1,2-a][1,4]diazepine | Ki | 7.0 [1] |
 | 2-N-[2-(4-Fluorophenoxy)ethyl]-4-N-[(1S)-1-phenylethyl]pyridine-2,4-diamine | Ki | 0.2 [1] |
 | 3,4-Dibromo-N-methyl-N-[(2R)-4-(4-methylpiperidin-1-yl)butan-2-yl]benzenesulfonamide | Ki | 19.95 [1] |
 | N-Methyl-N-[(2R)-4-[(3R)-3-methylpiperidin-1-yl]butan-2-yl]naphthalene-1-sulfonamide | Ki | 125.89 [1] |
 | N-Methyl-N-[(2S)-4-[(3S)-3-methylpiperidin-1-yl]butan-2-yl]naphthalene-1-sulfonamide | Ki | 10000.0 [1] |
 | 3,4-Dichloro-N-methyl-N-[(2R)-4-(4-methylpiperidin-1-yl)butan-2-yl]benzenesulfonamide | Ki | 31.62 [1] |
 | (2S)-1-(1-Naphthylsulfonyl)-2-[2-(4-methylpiperidino)ethyl]piperidine | Ki | 15.85 [1], 398.11 [2] |
 | 4,5-Dibromo-N-methyl-N-[(2R)-4-(4-methylpiperidin-1-yl)butan-2-yl]thiophene-2-sulfonamide | Ki | 15.85 [1] |
 | N-Methyl-N-[(2S)-4-[(3R)-3-methylpiperidin-1-yl]butan-2-yl]naphthalene-1-sulfonamide | Ki | 1584.89 [1] |
 | 2a-[4-[4-(4-Fluorophenyl)-3,6-dihydro-2H-pyridin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one | Ki | 3.55 [1] |
 | 2a-[4-(4-Phenylpiperidin-1-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one | Ki | 2.0 [1], 3.98 [2] |
 | 3-Ethyl-3-[4-[4-(4-fluorophenyl)-3,6-dihydro-2H-pyridin-1-yl]butyl]-1H-indol-2-one | Ki | 1.19 [1], 1.2 [2] |
 | 3-{4-[4-(4-Chlorophenyl)-piperazin-1-yl]-butyl}-3-ethyl-1,3-dihydro-2H-indol-2-one | Ki | 0.38 [1] |
 | 5,7-Dichloro-3-[4-[4-(4-chlorophenyl)piperazin-1-yl]butyl]-3-ethyl-1H-indol-2-one | Ki | 9.5 [1], 10.13 [2] |
 | 3-{4-[4-(4-Chlorophenyl)-piperazin-1-yl]-butyl}-1,3-dihydro-2H-indol-2-one | Ki | 0.38 [1], 7.0 [2] |
 | 3-Ethyl-3-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]-1H-indol-2-one | Ki | 5.38 [1], 5.4 [2] |
 | 1-(2-Methoxyphenyl)-4-[1-(2-cyanophenyl)-1H-pyrrole-3-ylmethyl]piperazine | Ki | 5.4 [1] |
 | 3-[4-[4-(3-Chlorophenyl)piperazin-1-yl]butyl]-3-ethyl-5-fluoro-1H-indol-2-one | Ki | 2.1 [1], 2.11 [2] |
 | 3-{4-[4-(3-Chlorophenyl)-piperazin-1-yl]-butyl}-1,3-dihydro-2H-indol-2-one | Ki | 0.49 [1] |
 | Methyl 2-(3-((4-(2-methoxyphenyl)piperazin-1-yl)methyl)-1H-pyrrol-1-yl)-3-methylbenzoate | Ki | 18.0 [1] |
 | 3-{4-[4-(4-Chlorophenyl)-piperazin-1-yl]-butyl}-3-ethyl-5-fluoro-1,3-dihydro-2H-indol-2-one | Ki | 2.81 [1] |
Calculator
